Related Experiment Video
Updated: Jul 16, 2026
08:32
A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
Published on: March 20, 2026
Juvenile idiopathic arthritis.
Angelo Ravelli1, Alberto Martini1
1Department of Paediatrics, University of Genoa and Institute G. Gaslini, Genoa, Italy.
Lancet (London, England)
|March 6, 2007
Summary
Juvenile idiopathic arthritis (JIA) is a complex condition with varied presentations. Advances in treatment, including anticytokine agents, have improved patient outcomes, though a cure remains elusive.
Area of Science:
- Rheumatology
- Immunology
- Pediatrics
Background:
- Juvenile idiopathic arthritis (JIA) is a heterogeneous group of inflammatory joint diseases of unknown etiology starting before age 16.
- The exact causes are poorly understood, involving a complex interplay of genetic and environmental factors.
- JIA presents with diverse clinical manifestations, symptoms, and distinct genetic backgrounds across its subtypes.
Purpose of the Study:
- To provide an overview of juvenile idiopathic arthritis, encompassing its heterogeneity and current understanding.
- To highlight recent advancements in the management and treatment of JIA.
- To discuss the future directions in JIA research, focusing on pathogenesis and novel therapeutic targets.
Main Methods:
- Literature review of current research on JIA.
- Analysis of recent clinical trial data for JIA treatments.
- Synthesis of information on disease mechanisms and immunopathology.
Main Results:
- Prognosis for JIA has significantly improved due to enhanced disease management strategies.
- Anticytokine agents represent a major therapeutic advancement, offering a valuable option for refractory cases.
- Despite progress, current therapies lack curative potential, emphasizing the need for further research.
Conclusions:
- Understanding the immune response and inflammatory pathways is crucial for advancing JIA treatment.
- Development of targeted therapies inhibiting specific molecules or pathways holds promise for future JIA management.
- Continued research into JIA pathogenesis is essential for developing curative strategies and improving long-term outcomes.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:10Ankle Joint
The ankle is formed by the talocrural joint (crural = leg). It consists of the articulations between the talus bone of the foot and the distal ends of the tibia and fibula of the leg. The superior aspect of the talus bone is square-shaped and has three areas of articulation. The top of the talus articulates with the inferior tibia. This is the portion of the ankle joint that carries the body weight between the leg and foot. The sides of the talus are firmly held in position by the articulations...
01:07Development of the Limb Synovial Joints
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...